Theramine® is a medical food indicated for the dietary management of pain syndromes. It is a specialized formulation that provides the body with the precursors to the pain modulating neurotransmitters serotonin, GABA, acetyl- choline, histamine and nitric oxide. Theramine® utilizes patented Targeted Cellular Technology to maximize cellular uptake and utilization of mg amounts of free amino acids.
Theramine® is a non-addictive, safe and clinically validated therapeutic option for the management of pain syndromes. Theramine is effective at managing ascending, descending and inflammatory pathways associated with pain syndromes.
- Is Non-Addictive
- Has No Reported GI Bleeds
- Reduces Pain
- Reduces Inflammation
- Over 26 Million Doses Taken Without a Reported Adverse Side Effect
Theramine® is indicated for acute and chronic pain, fibromyalgia, neuropathic pain, and inflammatory pain.
Suggested dosing: Take two (2) capsules twice daily or as needed.
Improves Pain Perception* (muscle, joint, nerve)
Reduces Inflammation* Effective Alternative to NSAIDs, Anti-epileptics and Addictive Narcotic Pain Medications
In a 28 day double-blind multicenter trial of 127 subjects with chronic established back pain, subjects taking Theramine experienced a 76% reduction in pain compared to once daily Naprosyn (250mg) as measured by the Roland Morris Index.*
Shell, et al. A Double Blind Controlled Trial of a Single Dose Naproxen and an Amino Acid Medical Food, Theramine for the Treatment of Low Back Pain. American Journal of Therapeutics, 2012
ADVERSE REACTIONS: Ingestion of L-Tryptophan, L-Arginine, or Choline at high doses of up to 15 grams daily is generally well tolerated. The most common adverse reactions of higher doses — from 15 to 30 grams daily — are nausea, abdominal cramps, and diarrhea. Theramine contains less than 1 gram per dose of amino acids however, some patients may experience these symptoms at lower doses. The total combined amount of amino acids in each Theramine capsule does not exceed 400 mg.
DRUG INTERACTIONS: Theramine does not directly infuence the pharmacokinetics of prescription drugs. Clinical experience has shown that administration of Theramine may allow for lowering the dose of co-administered drugs under physician supervision.